| Year |
Citation |
Score |
| 2020 |
Khadke S, Roces CB, Donaghey R, Giacobbo V, Su Y, Perrie Y. Scalable solvent-free production of liposomes. The Journal of Pharmacy and Pharmacology. PMID 32671856 DOI: 10.1111/Jphp.13329 |
0.328 |
|
| 2020 |
Shah S, Dhawan V, Holm R, Nagarsenker MS, Perrie Y. Liposomes: Advancements and innovation in the manufacturing process. Advanced Drug Delivery Reviews. PMID 32650041 DOI: 10.1016/J.Addr.2020.07.002 |
0.307 |
|
| 2020 |
Roces CB, Port EC, Daskalakis NN, Watts JA, Aylott JW, Halbert GW, Perrie Y. Rapid scale-up and production of active-loaded PEGylated liposomes. International Journal of Pharmaceutics. 586: 119566. PMID 32622812 DOI: 10.1016/J.Ijpharm.2020.119566 |
0.357 |
|
| 2020 |
Lou G, Anderluzzi G, Tandrup Schmidt S, Woods S, Gallorini S, Brazzoli M, Giusti F, Ferlenghi I, Johnson R, Roberts CW, O'Hagan DT, Baudner BC, Perrie Y. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32619745 DOI: 10.1016/J.Jconrel.2020.06.027 |
0.384 |
|
| 2020 |
Chatzikleanthous D, Cunliffe R, Carboni F, Romano MR, O'Hagan DT, Roberts CW, Perrie Y, Adamo R. Synthesis of protein conjugates adsorbed on cationic liposomes surface. Methodsx. 7: 100942. PMID 32551244 DOI: 10.1016/J.Mex.2020.100942 |
0.352 |
|
| 2020 |
Warraich AA, Mohammed AR, Perrie Y, Hussain M, Gibson H, Rahman A. Evaluation of anti-biofilm activity of acidic amino acids and synergy with ciprofloxacin on Staphylococcus aureus biofilms. Scientific Reports. 10: 9021. PMID 32488138 DOI: 10.1038/S41598-020-66082-X |
0.624 |
|
| 2020 |
Anderluzzi G, Lou G, Gallorini S, Brazzoli M, Johnson R, O'Hagan DT, Baudner BC, Perrie Y. Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines. Vaccines. 8. PMID 32397231 DOI: 10.3390/Vaccines8020212 |
0.373 |
|
| 2020 |
Chatzikleanthous D, Schmidt ST, Buffi G, Paciello I, Cunliffe R, Carboni F, Romano MR, O'Hagan DT, D'Oro U, Woods S, Roberts CW, Perrie Y, Adamo R. Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32247804 DOI: 10.1016/J.Jconrel.2020.04.001 |
0.402 |
|
| 2020 |
Roces CB, Christensen D, Perrie Y. Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics. Drug Delivery and Translational Research. PMID 31919746 DOI: 10.1007/S13346-019-00699-Y |
0.331 |
|
| 2019 |
Roces CB, Hussain MT, Schmidt ST, Christensen D, Perrie Y. Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting. Vaccines. 8. PMID 31906072 DOI: 10.3390/Vaccines8010010 |
0.389 |
|
| 2019 |
Webb C, Khadke S, Schmidt ST, Roces CB, Forbes N, Berrie G, Perrie Y. The Impact of Solvent Selection: Strategies to Guide the Manufacturing of Liposomes Using Microfluidics. Pharmaceutics. 11. PMID 31817217 DOI: 10.3390/Pharmaceutics11120653 |
0.345 |
|
| 2019 |
Hussain MT, Forbes N, Perrie Y, Malik KP, Duru C, Matejtschuk P. Freeze-drying cycle optimization for the rapid preservation of protein- loaded liposomal formulations. International Journal of Pharmaceutics. 118722. PMID 31705976 DOI: 10.1016/J.Ijpharm.2019.118722 |
0.339 |
|
| 2019 |
Koner JS, Rajabi-Siahboomi AR, Missaghi S, Kirby D, Perrie Y, Ahmed J, Mohammed AR. Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets. Scientific Reports. 9: 12467. PMID 31462654 DOI: 10.1038/S41598-019-48859-X |
0.638 |
|
| 2019 |
Lou G, Anderluzzi G, Woods S, Roberts CW, Perrie Y. A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: formulation, cellular uptake and biodistribution investigations. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 31445156 DOI: 10.1016/J.Ejpb.2019.08.013 |
0.359 |
|
| 2019 |
Roces CB, Khadke S, Christensen D, Perrie Y. Scale-independent microfluidic production of cationic liposomal adjuvants and development of enhanced lymphatic targeting strategies. Molecular Pharmaceutics. PMID 31437396 DOI: 10.1021/Acs.Molpharmaceut.9B00730 |
0.358 |
|
| 2019 |
Joshi S, Bawage S, Tiwari P, Kirby D, Perrie Y, Dennis V, Singh SR. Liposomes: A promising carrier for respiratory syncytial virus therapeutics. Expert Opinion On Drug Delivery. PMID 31382795 DOI: 10.1080/17425247.2019.1652268 |
0.342 |
|
| 2019 |
Khadke S, Roces CB, Cameron A, Devitt A, Perrie Y. Formulation and manufacturing of lymphatic targeting liposomes using microfluidics. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31170464 DOI: 10.1016/J.Jconrel.2019.06.002 |
0.387 |
|
| 2019 |
Wahlich J, Desai A, Greco F, Hill K, Jones AT, Mrsny RJ, Pasut G, Perrie Y, Seib FP, Seymour LW, Uchegbu IF. Nanomedicines for the Delivery of Biologics. Pharmaceutics. 11. PMID 31058802 DOI: 10.3390/Pharmaceutics11050210 |
0.338 |
|
| 2019 |
Marwah M, Perrie Y, Badhan RKS, Lowry D. Intracellular uptake of EGCG-loaded deformable controlled release liposomes for skin cancer. Journal of Liposome Research. 1-42. PMID 31010367 DOI: 10.1080/08982104.2019.1604746 |
0.343 |
|
| 2019 |
Pollard J, Rajabi-Siahboomi A, Badhan RKS, Mohammed AR, Perrie Y. High-throughput screening of excipients with a biological effect: a kinetic study on the effects of surfactants on efflux-mediated transport. The Journal of Pharmacy and Pharmacology. PMID 30784086 DOI: 10.1111/Jphp.13072 |
0.61 |
|
| 2019 |
D'Elia RV, Woods S, Butcher W, McGahon J, Khadke S, Perrie Y, Williamson ED, Roberts CW. Exploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatments. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30731152 DOI: 10.1016/J.Jconrel.2019.02.002 |
0.306 |
|
| 2019 |
Hussain MT, Forbes N, Perrie Y. Comparative Analysis of Protein Quantification Methods for the Rapid Determination of Protein Loading in Liposomal Formulations. Pharmaceutics. 11. PMID 30669330 DOI: 10.3390/Pharmaceutics11010039 |
0.32 |
|
| 2018 |
Forbes N, Hussain MT, Briuglia ML, Edwards DY, Horst JHT, Szita N, Perrie Y. Rapid and scale-independent microfluidic manufacture of liposomes entrapping protein incorporating in-line purification and at-line size monitoring. International Journal of Pharmaceutics. PMID 30503269 DOI: 10.1016/J.Ijpharm.2018.11.060 |
0.322 |
|
| 2018 |
Wilkinson A, Lattmann E, Roces CB, Pedersen G, Christensen D, Perrie Y. Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30291987 DOI: 10.1016/J.Jconrel.2018.10.002 |
0.34 |
|
| 2018 |
Gadd AJR, Castelletto V, Kabova E, Shankland K, Perrie Y, Hamley I, Cobb AJA, Greco F, Edwards AD. High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 123: 268-276. PMID 30048801 DOI: 10.1016/J.Ejps.2018.07.048 |
0.349 |
|
| 2018 |
Marín-García M, Benseny-Cases N, Camacho M, Perrie Y, Suades J, Barnadas-Rodríguez R. Metallosomes for biomedical applications by mixing molybdenum carbonyl metallosurfactants and phospholipids. Dalton Transactions (Cambridge, England : 2003). 47: 14293-14303. PMID 29951684 DOI: 10.1039/C8Dt01584H |
0.308 |
|
| 2017 |
Khadke S, Stone P, Rozhin A, Kroonen J, Perrie Y. Point of use production of liposomal solubilised products. International Journal of Pharmaceutics. 537: 1-8. PMID 29225099 DOI: 10.1016/J.Ijpharm.2017.12.012 |
0.383 |
|
| 2017 |
Dimov N, Kastner E, Hussain M, Perrie Y, Szita N. Formation and purification of tailored liposomes for drug delivery using a module-based micro continuous-flow system. Scientific Reports. 7: 12045. PMID 28935923 DOI: 10.1038/S41598-017-11533-1 |
0.415 |
|
| 2017 |
Wilkhu JS, Mcneil SE, Anderson DE, Kirchmeier M, Perrie Y. Development of a solid dosage platform for the oral delivery of bilayer vesicles. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 28619620 DOI: 10.1016/J.Ejps.2017.06.014 |
0.432 |
|
| 2017 |
Miriyala N, Ouyang D, Perrie Y, Lowry D, Kirby DJ. Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 28284728 DOI: 10.1016/J.Ejpb.2017.03.002 |
0.374 |
|
| 2017 |
Perrie Y, Kastner E, Khadke S, Roces CB, Stone P. Manufacturing Methods for Liposome Adjuvants. Methods in Molecular Biology (Clifton, N.J.). 1494: 127-144. PMID 27718190 DOI: 10.1007/978-1-4939-6445-1_9 |
0.355 |
|
| 2016 |
Joshi S, Hussain MT, Roces CB, Anderluzzi G, Kastner E, Salmaso S, Kirby DJ, Perrie Y. Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs. International Journal of Pharmaceutics. 514: 160-168. PMID 27863660 DOI: 10.1016/J.Ijpharm.2016.09.027 |
0.407 |
|
| 2016 |
Roces CB, Kastner E, Stone P, Lowry D, Perrie Y. Rapid Quantification and Validation of Lipid Concentrations within Liposomes. Pharmaceutics. 8. PMID 27649231 DOI: 10.3390/Pharmaceutics8030029 |
0.342 |
|
| 2016 |
Perrie Y, Crofts F, Devitt A, Griffiths HR, Kastner E, Nadella V. Designing liposomal adjuvants for the next generation of vaccines. Advanced Drug Delivery Reviews. 99: 85-96. PMID 26576719 DOI: 10.1016/J.Addr.2015.11.005 |
0.411 |
|
| 2016 |
Kastner E, Hussain MJ, Bramwell VW, Christensen D, Perrie Y. Correlating liposomal adjuvant characteristics to in-vivo cell-mediated immunity using a novel Mycobacterium tuberculosis fusion protein: A multivariate analysis study Journal of Pharmacy and Pharmacology. 67: 450-463. PMID 25677402 DOI: 10.1111/Jphp.12390 |
0.319 |
|
| 2015 |
Koner JS, Rajabi-Siahboomi A, Bowen J, Perrie Y, Kirby D, Mohammed AR. A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline Mannitol. Scientific Reports. 5: 16352. PMID 26553127 DOI: 10.1038/Srep16352 |
0.635 |
|
| 2015 |
Al-Khattawi A, Koner J, Rue P, Kirby D, Perrie Y, Rajabi-Siahboomi A, Mohammed AR. A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 94: 1-10. PMID 25960332 DOI: 10.1016/J.Ejpb.2015.04.011 |
0.731 |
|
| 2015 |
Russell C, Begum S, Hussain Y, Hussain M, Huen D, Rahman AS, Perrie Y, Mohammed AR. Paediatric drug development of ramipril: reformulation, in vitro and in vivo evaluation. Journal of Drug Targeting. 1-10. PMID 25950602 DOI: 10.3109/1061186X.2015.1036275 |
0.645 |
|
| 2015 |
Perrie Y, Griffiths HR, Jones D. Enhancing vaccine design strategies: applications for protein science, proteomics and adjuvants. The Journal of Pharmacy and Pharmacology. 67: 287-9. PMID 25819112 DOI: 10.1111/Jphp.12414 |
0.303 |
|
| 2015 |
Kastner E, Verma V, Lowry D, Perrie Y. Microfluidic-controlled manufacture of liposomes for the solubilisation of a poorly water soluble drug. International Journal of Pharmaceutics. 485: 122-30. PMID 25725309 DOI: 10.1016/J.Ijpharm.2015.02.063 |
0.389 |
|
| 2014 |
Wilkhu JS, McNeil SE, Anderson DE, Perrie Y. Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines. Drug Delivery and Translational Research. 4: 233-45. PMID 25786878 DOI: 10.1007/S13346-013-0174-7 |
0.412 |
|
| 2014 |
Kastner E, Kaur R, Lowry D, Moghaddam B, Wilkinson A, Perrie Y. High-throughput manufacturing of size-tuned liposomes by a new microfluidics method using enhanced statistical tools for characterization. International Journal of Pharmaceutics. 477: 361-8. PMID 25455778 DOI: 10.1016/J.Ijpharm.2014.10.030 |
0.327 |
|
| 2014 |
Wilkhu JS, Ouyang D, Kirchmeier MJ, Anderson DE, Perrie Y. Investigating the role of cholesterol in the formation of non-ionic surfactant based bilayer vesicles: thermal analysis and molecular dynamics. International Journal of Pharmaceutics. 461: 331-41. PMID 24333900 DOI: 10.1016/J.Ijpharm.2013.11.063 |
0.326 |
|
| 2014 |
Hussain MJ, Wilkinson A, Bramwell VW, Christensen D, Perrie Y. Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants. The Journal of Pharmacy and Pharmacology. 66: 358-66. PMID 24251796 DOI: 10.1111/Jphp.12173 |
0.34 |
|
| 2014 |
Kaur R, Henriksen-Lacey M, Wilkhu J, Devitt A, Christensen D, Perrie Y. Effect of incorporating cholesterol into DDA:TDB liposomal adjuvants on bilayer properties, biodistribution, and immune responses. Molecular Pharmaceutics. 11: 197-207. PMID 24171445 DOI: 10.1021/Mp400372J |
0.359 |
|
| 2013 |
Wilkhu JS, McNeil SE, Anderson DE, Perrie Y. Characterization and optimization of bilosomes for oral vaccine delivery. Journal of Drug Targeting. 21: 291-299. PMID 30952177 DOI: 10.3109/1061186X.2012.747528 |
0.414 |
|
| 2013 |
Perrie Y, Kastner E, Kaur R, Wilkinson A, Ingham AJ. A case-study investigating the physicochemical characteristics that dictate the function of a liposomal adjuvant. Human Vaccines & Immunotherapeutics. 9: 1374-81. PMID 23584249 DOI: 10.4161/Hv.24694 |
0.392 |
|
| 2013 |
Kirby DJ, Kaur R, Agger EM, Andersen P, Bramwell VW, Perrie Y. Developing solid particulate vaccine adjuvants: surface bound antigen favours a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity. Current Drug Delivery. 10: 268-78. PMID 23410072 DOI: 10.2174/1567201811310030003 |
0.336 |
|
| 2013 |
Ali MH, Moghaddam B, Kirby DJ, Mohammed AR, Perrie Y. The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs. International Journal of Pharmaceutics. 453: 225-32. PMID 22766442 DOI: 10.1016/J.Ijpharm.2012.06.056 |
0.684 |
|
| 2013 |
Khan S, Batchelor H, Hanson P, Saleem IY, Perrie Y, Mohammed AR. Dissolution rate enhancement, in vitro evaluation and investigation of drug release kinetics of chloramphenicol and sulphamethoxazole solid dispersions. Drug Development and Industrial Pharmacy. 39: 704-15. PMID 22639985 DOI: 10.3109/03639045.2012.689763 |
0.685 |
|
| 2012 |
Kaur R, Bramwell VW, Kirby DJ, Perrie Y. Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response. Journal of Controlled Release : Official Journal of the Controlled Release Society. 164: 331-7. PMID 22800572 DOI: 10.1016/J.Jconrel.2012.07.012 |
0.372 |
|
| 2012 |
Christensen D, Henriksen-Lacey M, Kamath AT, Lindenstrøm T, Korsholm KS, Christensen JP, Rochat AF, Lambert PH, Andersen P, Siegrist CA, Perrie Y, Agger EM. A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog. Journal of Controlled Release : Official Journal of the Controlled Release Society. 160: 468-76. PMID 22709414 DOI: 10.1016/J.Jconrel.2012.03.016 |
0.374 |
|
| 2012 |
Milicic A, Kaur R, Reyes-Sandoval A, Tang CK, Honeycutt J, Perrie Y, Hill AV. Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses. Plos One. 7: e34255. PMID 22470545 DOI: 10.1371/Journal.Pone.0034255 |
0.357 |
|
| 2012 |
Perrie Y, Badhan RK, Kirby DJ, Lowry D, Mohammed AR, Ouyang D. The impact of ageing on the barriers to drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 161: 389-98. PMID 22289435 DOI: 10.1016/J.Jconrel.2012.01.020 |
0.657 |
|
| 2012 |
Bibi S, Lattmann E, Mohammed AR, Perrie Y. Trigger release liposome systems: local and remote controlled delivery? Journal of Microencapsulation. 29: 262-76. PMID 22208705 DOI: 10.3109/02652048.2011.646330 |
0.666 |
|
| 2012 |
Kaur R, Bramwell VW, Kirby DJ, Perrie Y. Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses. Journal of Controlled Release : Official Journal of the Controlled Release Society. 158: 72-7. PMID 22032883 DOI: 10.1016/J.Jconrel.2011.10.012 |
0.338 |
|
| 2012 |
Gregoriadis G, McCormack B, Obrenovich M, Perrie Y. Entrapment of plasmid DNA vaccines into liposomes by dehydration/rehydration. Methods in Molecular Medicine. 29: 305-11. PMID 21374330 DOI: 10.1385/1-59259-688-6:305 |
0.558 |
|
| 2012 |
Al-Khattawi A, Aly A, Perrie Y, Rue P, R Mohammed A. Multi Stage Strategy to Reduce Friability of Directly Compressed Orally Disintegrating Tablets Drug Delivery Letters. 2: 195-201. DOI: 10.2174/2210304X11202030195 |
0.739 |
|
| 2011 |
Shabir A, Alhusban F, Perrie Y, Mohammed AR. Effects of ball-milling on PLGA polymer and its implication on lansoprazole-loaded nanoparticles. Journal of Basic and Clinical Pharmacy. 2: 71-82. PMID 24826005 |
0.617 |
|
| 2011 |
Jones RJ, Rajabi-Siahboomi A, Levina M, Perrie Y, Mohammed AR. The influence of formulation and manufacturing process parameters on the characteristics of lyophilized orally disintegrating tablets. Pharmaceutics. 3: 440-57. PMID 24310589 DOI: 10.3390/Pharmaceutics3030440 |
0.662 |
|
| 2011 |
Moghaddam B, McNeil SE, Zheng Q, Mohammed AR, Perrie Y. Exploring the correlation between lipid packaging in lipoplexes and their transfection efficacy. Pharmaceutics. 3: 848-64. PMID 24309311 DOI: 10.3390/Pharmaceutics3040848 |
0.681 |
|
| 2011 |
Wilkhu J, McNeil SE, Kirby DJ, Perrie Y. Formulation design considerations for oral vaccines. Therapeutic Delivery. 2: 1141-64. PMID 22833911 DOI: 10.4155/Tde.11.82 |
0.364 |
|
| 2011 |
Alhusban F, Perrie Y, Mohammed AR. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 79: 627-34. PMID 21693189 DOI: 10.1016/J.Ejpb.2011.05.014 |
0.674 |
|
| 2011 |
Henriksen-Lacey M, Devitt A, Perrie Y. The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production. Journal of Controlled Release : Official Journal of the Controlled Release Society. 154: 131-7. PMID 21640145 DOI: 10.1016/J.Jconrel.2011.05.019 |
0.369 |
|
| 2011 |
Carstens MG, Camps MG, Henriksen-Lacey M, Franken K, Ottenhoff TH, Perrie Y, Bouwstra JA, Ossendorp F, Jiskoot W. Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines. Vaccine. 29: 4761-70. PMID 21565240 DOI: 10.1016/J.Vaccine.2011.04.081 |
0.388 |
|
| 2011 |
Khan S, Batchelor H, Hanson P, Perrie Y, Mohammed AR. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000. Journal of Pharmaceutical Sciences. 100: 4281-94. PMID 21560130 DOI: 10.1002/Jps.22613 |
0.673 |
|
| 2011 |
Henriksen-Lacey M, Korsholm KS, Andersen P, Perrie Y, Christensen D. Liposomal vaccine delivery systems. Expert Opinion On Drug Delivery. 8: 505-19. PMID 21413904 DOI: 10.1517/17425247.2011.558081 |
0.397 |
|
| 2011 |
McNeil SE, Rosenkrands I, Agger EM, Andersen P, Perrie Y. Subunit vaccines: distearoylphosphatidylcholine-based liposomes entrapping antigen offer a neutral alternative to dimethyldioctadecylammonium-based cationic liposomes as an adjuvant delivery system. Journal of Pharmaceutical Sciences. 100: 1856-65. PMID 21374619 DOI: 10.1002/Jps.22427 |
0.399 |
|
| 2011 |
Kaur R, Chen J, Dawoodji A, Cerundolo V, Garcia-Diaz YR, Wojno J, Cox LR, Besra GS, Moghaddam B, Perrie Y. Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells. Journal of Pharmaceutical Sciences. 100: 2724-33. PMID 21283989 DOI: 10.1002/Jps.22500 |
0.321 |
|
| 2011 |
Moghaddam B, Ali MH, Wilkhu J, Kirby DJ, Mohammed AR, Zheng Q, Perrie Y. The application of monolayer studies in the understanding of liposomal formulations. International Journal of Pharmaceutics. 417: 235-44. PMID 21251964 DOI: 10.1016/J.Ijpharm.2011.01.020 |
0.681 |
|
| 2011 |
Khan S, Elshaer A, Rahman AS, Hanson P, Perrie Y, Mohammed AR. Systems biology approach to study permeability of paracetamol and its solid dispersion. International Journal of Pharmaceutics. 417: 272-9. PMID 21187133 DOI: 10.1016/J.Ijpharm.2010.12.029 |
0.66 |
|
| 2011 |
Bibi S, Kaur R, Henriksen-Lacey M, McNeil SE, Wilkhu J, Lattmann E, Christensen D, Mohammed AR, Perrie Y. Microscopy imaging of liposomes: from coverslips to environmental SEM. International Journal of Pharmaceutics. 417: 138-50. PMID 21182914 DOI: 10.1016/J.Ijpharm.2010.12.021 |
0.628 |
|
| 2011 |
Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstrøm T, Agger EM, Andersen P, Perrie Y. Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses. Molecular Pharmaceutics. 8: 153-61. PMID 21117621 DOI: 10.1021/Mp100208F |
0.376 |
|
| 2011 |
Khan S, Elshaer A, Rahman AS, Hanson P, Perrie Y, Mohammed AR. Genomic evaluation during permeability of indomethacin and its solid dispersion. Journal of Drug Targeting. 19: 615-23. PMID 21080758 DOI: 10.3109/1061186X.2010.531730 |
0.654 |
|
| 2010 |
Henriksen-Lacey M, Bramwell V, Perrie Y. Radiolabelling of Antigen and Liposomes for Vaccine Biodistribution Studies. Pharmaceutics. 2: 91-104. PMID 27721345 DOI: 10.3390/Pharmaceutics2020091 |
0.363 |
|
| 2010 |
AlHusban F, ElShaer AM, Kansara JH, Smith AM, Grover LM, Perrie Y, Mohammed AR. Investigation of Formulation and Process of Lyophilised Orally Disintegrating Tablet (ODT) Using Novel Amino Acid Combination. Pharmaceutics. 2: 1-17. PMID 27721339 DOI: 10.3390/Pharmaceutics2010001 |
0.664 |
|
| 2010 |
Ali MH, Kirby DJ, Mohammed AR, Perrie Y. Solubilisation of drugs within liposomal bilayers: Alternatives to cholesterol as a membrane stabilising agent Journal of Pharmacy and Pharmacology. 62: 1646-1655. PMID 21039548 DOI: 10.1111/J.2042-7158.2010.01090.X |
0.671 |
|
| 2010 |
Perrie Y, Rades T. Themed issue: improve dissolution, solubility and bioavailability of poorly soluble drugs. The Journal of Pharmacy and Pharmacology. 62: 1517-8. PMID 21039536 DOI: 10.1111/J.2042-7158.2010.01199.X |
0.35 |
|
| 2010 |
Mohammed AR, Bramwell VW, Kirby DJ, McNeil SE, Perrie Y. Increased potential of a cationic liposome-based delivery system: Enhancing stability and sustained immunological activity in pre-clinical development European Journal of Pharmaceutics and Biopharmaceutics. 76: 404-412. PMID 20884349 DOI: 10.1016/J.Ejpb.2010.09.008 |
0.678 |
|
| 2010 |
Mohanan D, Slütter B, Henriksen-Lacey M, Jiskoot W, Bouwstra JA, Perrie Y, Kündig TM, Gander B, Johansen P. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. Journal of Controlled Release : Official Journal of the Controlled Release Society. 147: 342-9. PMID 20727926 DOI: 10.1016/J.Jconrel.2010.08.012 |
0.345 |
|
| 2010 |
Smith AM, Ingham A, Grover LM, Perrie Y. Polymer film formulations for the preparation of enteric pharmaceutical capsules. The Journal of Pharmacy and Pharmacology. 62: 167-72. PMID 20487195 DOI: 10.1211/Jpp.62.02.0003 |
0.316 |
|
| 2010 |
Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstrøm T, Agger EM, Andersen P, Perrie Y. Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. Journal of Controlled Release : Official Journal of the Controlled Release Society. 145: 102-8. PMID 20381556 DOI: 10.1016/J.Jconrel.2010.03.027 |
0.345 |
|
| 2010 |
AlHusban F, Perrie Y, Mohammed AR. Formulation and characterisation of lyophilised rapid disintegrating tablets using amino acids as matrix forming agents. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 75: 254-62. PMID 20332027 DOI: 10.1016/J.Ejpb.2010.03.012 |
0.636 |
|
| 2010 |
McNeil SE, Vangala A, Bramwell VW, Hanson PJ, Perrie Y. Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies. Current Drug Delivery. 7: 175-87. PMID 20158478 DOI: 10.2174/156720110791011774 |
0.402 |
|
| 2010 |
Perrie Y, Ali H, Kirby DJ, Mohammed AU, McNeil SE, Vangala A. Environmental scanning electron microscope imaging of vesicle systems Methods in Molecular Biology (Clifton, N.J.). 606: 319-331. PMID 20013405 DOI: 10.1007/978-1-60761-447-0_21 |
0.305 |
|
| 2010 |
Henriksen-Lacey M, Bramwell VW, Christensen D, Agger EM, Andersen P, Perrie Y. Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 180-6. PMID 19874860 DOI: 10.1016/J.Jconrel.2009.10.022 |
0.353 |
|
| 2010 |
AlHusban F, Perrie Y, Mohammed AR. Preparation, optimisation and characterisation of lyophilised rapid disintegrating tablets based on gelatin and saccharide. Current Drug Delivery. 7: 65-75. PMID 19863486 DOI: 10.2174/156720110790396427 |
0.655 |
|
| 2010 |
Chang H-, Wang Y, Perrie Y, Coombes AGA. Microporous polycaprolactone matrices for drug delivery and tissue engineering: the release behaviour of bioactives having extremes of aqueous solubility Journal of Drug Delivery Science and Technology. 20: 207-212. DOI: 10.1016/S1773-2247(10)50031-5 |
0.368 |
|
| 2009 |
Christensen D, Agger EM, Andreasen LV, Kirby D, Andersen P, Perrie Y. Liposome-based cationic adjuvant formulations (CAF): past, present, and future. Journal of Liposome Research. 19: 2-11. PMID 19515003 DOI: 10.1080/08982100902726820 |
0.359 |
|
| 2009 |
Perrie Y, Mohammed A. Pharmaceutics: A New Open-Access Journal for All Those Interested in Designing Medicines Pharmaceutics. 1: 1-2. DOI: 10.3390/Pharmaceutics1010001 |
0.659 |
|
| 2008 |
Hofmann MP, Mohammed AR, Perrie Y, Gbureck U, Barralet JE. High-strength resorbable brushite bone cement with controlled drug-releasing capabilities. Acta Biomaterialia. 5: 43-9. PMID 18799378 DOI: 10.1016/J.Actbio.2008.08.005 |
0.349 |
|
| 2008 |
Clark S, Cross ML, Smith A, Court P, Vipond J, Nadian A, Hewinson RG, Batchelor HK, Perrie Y, Williams A, Aldwell FE, Chambers MA. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis. Vaccine. 26: 5791-7. PMID 18789366 DOI: 10.1016/J.Vaccine.2008.08.028 |
0.372 |
|
| 2008 |
Kirby DJ, Rosenkrands I, Agger EM, Andersen P, Coombes AG, Perrie Y. Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres. Journal of Drug Targeting. 16: 543-54. PMID 18686124 DOI: 10.1080/10611860802228558 |
0.391 |
|
| 2008 |
Perrie Y. Gregory Gregoriadis: Introducing liposomes to drug delivery. Journal of Drug Targeting. 16: 518-9. PMID 18686119 DOI: 10.1080/10611860802228376 |
0.367 |
|
| 2008 |
Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW. Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens International Journal of Pharmaceutics. 364: 272-280. PMID 18555624 DOI: 10.1016/J.Ijpharm.2008.04.036 |
0.674 |
|
| 2008 |
Kirby DJ, Rosenkrands I, Agger EM, Andersen P, Coombes AGA, Perrie Y. PLGA microspheres for the delivery of a novel subunit TB vaccine Journal of Drug Targeting. 16: 282-293. PMID 18446607 DOI: 10.1080/10611860801900462 |
0.417 |
|
| 2008 |
Christensen D, Kirby D, Foged C, Agger EM, Andersen P, Perrie Y, Nielsen HM. alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying. Biochimica Et Biophysica Acta. 1778: 1365-73. PMID 18261458 DOI: 10.1016/J.Bbamem.2008.01.013 |
0.313 |
|
| 2007 |
Perrie Y, Kirby D, Bramwell VW, Mohammed AR. Recent developments in particulate-based vaccines. Recent Patents On Drug Delivery & Formulation. 1: 117-29. PMID 19075879 DOI: 10.2174/187221107780831897 |
0.676 |
|
| 2007 |
Vangala A, Morris R, Bencsik M, Perrie Y. Preparation and characterization of gas-filled liposomes: can they improve oil recovery? Journal of Liposome Research. 17: 263-72. PMID 18027246 DOI: 10.1080/08982100701528377 |
0.343 |
|
| 2007 |
Perrie Y, Mohammed AU, Vangala A, McNeil SE. Environmental scanning electron microscopy offers real-time morphological analysis of liposomes and niosomes. Journal of Liposome Research. 17: 27-37. PMID 17454401 DOI: 10.1080/08982100601186508 |
0.342 |
|
| 2007 |
Vangala A, Bramwell VW, McNeil S, Christensen D, Agger EM, Perrie Y. Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen. Journal of Controlled Release : Official Journal of the Controlled Release Society. 119: 102-10. PMID 17331610 DOI: 10.1016/J.Jconrel.2007.01.010 |
0.388 |
|
| 2007 |
Mohammed AR, Coombes AG, Perrie Y. Amino acids as cryoprotectants for liposomal delivery systems. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 30: 406-13. PMID 17317117 DOI: 10.1016/J.Ejps.2007.01.001 |
0.675 |
|
| 2006 |
Mohammed AR, Bramwell VW, Coombes AG, Perrie Y. Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products. Methods (San Diego, Calif.). 40: 30-8. PMID 16997711 DOI: 10.1016/J.Ymeth.2006.05.025 |
0.678 |
|
| 2006 |
Vangala A, Kirby D, Rosenkrands I, Agger EM, Andersen P, Perrie Y. A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice. The Journal of Pharmacy and Pharmacology. 58: 787-99. PMID 16734980 DOI: 10.1211/Jpp.58.6.0009 |
0.379 |
|
| 2006 |
Bramwell VW, Perrie Y. Particulate delivery systems for vaccines: what can we expect? The Journal of Pharmacy and Pharmacology. 58: 717-28. PMID 16734973 DOI: 10.1211/Jpp.58.6.0002 |
0.368 |
|
| 2006 |
McNeil SE, Perrie Y. Gene delivery using cationic liposomes Expert Opinion On Therapeutic Patents. 16: 1371-1382. DOI: 10.1517/13543776.16.10.1371 |
0.366 |
|
| 2005 |
Chang HI, Perrie Y, Coombes AGA. Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone. Journal of Controlled Release : Official Journal of the Controlled Release Society. 110: 414-421. PMID 16325955 DOI: 10.1016/J.Jconrel.2005.10.028 |
0.34 |
|
| 2005 |
Davidsen J, Rosenkrands I, Christensen D, Vangala A, Kirby D, Perrie Y, Agger EM, Andersen P. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses. Biochimica Et Biophysica Acta. 1718: 22-31. PMID 16321607 DOI: 10.1016/J.Bbamem.2005.10.011 |
0.353 |
|
| 2005 |
Bramwell VW, Perrie Y. The rational design of vaccines. Drug Discovery Today. 10: 1527-34. PMID 16257375 DOI: 10.1016/S1359-6446(05)03600-7 |
0.313 |
|
| 2005 |
Chang HI, Williamson MR, Perrie Y, Coombes AG. Precipitation casting of drug-loaded microporous PCL matrices: incorporation of progesterone by co-dissolution. Journal of Controlled Release : Official Journal of the Controlled Release Society. 106: 263-72. PMID 15993508 DOI: 10.1016/J.Jconrel.2005.05.013 |
0.365 |
|
| 2005 |
Bramwell VW, Perrie Y. Particulate delivery systems for vaccines. Critical Reviews in Therapeutic Drug Carrier Systems. 22: 151-214. PMID 15862111 DOI: 10.1615/Critrevtherdrugcarriersyst.V22.I2.20 |
0.369 |
|
| 2005 |
Mohammed AR, Weston N, Coombes AG, Fitzgerald M, Perrie Y. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. International Journal of Pharmaceutics. 285: 23-34. PMID 15488676 DOI: 10.1016/J.Ijpharm.2004.07.010 |
0.695 |
|
| 2004 |
Perrie Y, Barralet JE, McNeil S, Vangala A. Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route International Journal of Pharmaceutics. 284: 31-41. PMID 15454294 DOI: 10.1016/J.Ijpharm.2004.07.012 |
0.367 |
|
| 2003 |
Perrie Y, McNeil S, Vangala A. Liposome-mediated DNA immunisation via the subcutaneous route Journal of Drug Targeting. 11: 555-563. PMID 15203925 DOI: 10.1080/10611860410001670071 |
0.343 |
|
| 2002 |
Perrie Y, Obrenovic M, McCarthy D, Gregoriadis G. Liposome (Lipodine)-mediated DNA vaccination by the oral route. Journal of Liposome Research. 12: 185-97. PMID 12604053 DOI: 10.1081/Lpr-120004792 |
0.555 |
|
| 2001 |
Perrie Y, Frederik PM, Gregoriadis G. Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine. 19: 3301-10. PMID 11312029 DOI: 10.1016/S0264-410X(00)00432-1 |
0.59 |
|
| 2000 |
Perrie Y, Gregoriadis G. Liposome-entrapped plasmid DNA: characterisation studies. Biochimica Et Biophysica Acta. 1475: 125-32. PMID 10832026 DOI: 10.1016/S0304-4165(00)00055-6 |
0.552 |
|
| 1999 |
Gregoriadis G, McCormack B, Obrenovic M, Saffie R, Zadi B, Perrie Y. Vaccine entrapment in liposomes. Methods (San Diego, Calif.). 19: 156-62. PMID 10525452 DOI: 10.1006/Meth.1999.0841 |
0.586 |
|
| 1998 |
Obrenovic MM, Perrie Y, Gregoriadis G. Entrapment of plasmid DNA into niosomes: Characterization studies Journal of Pharmacy and Pharmacology. 50: 155-155. DOI: 10.1111/J.2042-7158.1998.Tb02355.X |
0.519 |
|
| 1998 |
Perrie Y, Gregoriadis G. Genetic immunization using liposome-incorporated DNA Journal of Pharmacy and Pharmacology. 50: 103-103. DOI: 10.1111/J.2042-7158.1998.Tb02303.X |
0.532 |
|
| Show low-probability matches. |